Abstract
New biological treatments are being developed at a record place, but their
potential could be compromised by a significant obstacle: the delivery of
these drugs into the body.
Pharmaceutical delivery is now nearly as important as product. New systems are
being developed, and Kalorama' s Drug Delivery Markets Series covers these new
systems.
The fourth volume of this series, Kalorama' s Drug Delivery Markets, Vol. IV:
Transdermal and Transmucosal Drug Delivery is a complete overview of a
delivery mechanism that offers some advantages: low pain, infection risk,
fewer side effects and polonged delivery over time.
Transdermal delivery has the advantage of being able deliver drugs over a long
period of time, deliver a substantial amount and do so in a way that causes no
pain or discomfort to the patient.
Nicotine patches have lead the growth in this delivery area, and patches are
the product most commonly associated with this area, but transdermal delivery
includes new transmission methods such as electrotransfer and iontophoresis.
Kalorama' s Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug
Delivery covers the entire market of drugs delivered through the skin or
muocus membrane, as well as the delivery technologies. The
transdermal/transmucosal drug delivery market is expected to grow steadily
with biotechnology drugs that require novel delivery technologies leading this
growth. The volume features
- Complete Round-Up of Key Companies
- Current Market Size for transdermal and transmucosal segments, as
well as the pharmaceutical and technology-only segments
- Forecasts to 2011 for Strategic Business Planning
- Complete Discussion of Delivery Technologies and how they operate.
- Review of Future Products
Market coverage includes both the pharmaceutical products that utilize the
drug delivery technology. The second section encompasses drug delivery
technology and the revenues earned from licensing that technology. Because
drug delivery technology is an integral part of sales of pharmaceuticals and
drug delivery technology cannot exist without pharmaceuticals, revenues have
been reported that include pharmaceutical sales for products utilizing that
technology.
This market is expected to increase substantially within the forecast period.
Additionally, a growing focus on ease of delivery to assist in patient
compliance could help drive demand for both transdermal and transmucosal
delivery systems.
Table of Contents
CHAPTER One: Executive Summary
- Market Drivers
- Market Size and Growth
- Total Transdermal/Transmucosal Drug Delivery Market
- Transdermal/Transmucosal Drug Delivery Only Market
- Competitive and Market Analysis
CHAPTER Two: Introduction and Overview
- Scope and Methodology
- Reasons for Transdermal/Transmucosal Drug Delivery Systems
- History of Transdermal and Transmucosal Drug Delivery
- Phases of Drug Action
- Topical Drug Delivery
- Types of Topical Preparations
- Market Participants
- Transdermal Patch Drug Delivery
- Membrane-Controlled System
- Adhesive Dispersion-Type System
- Matrix Diffusion-Controlled System
- Microreservoir Dissolution-Controlled System
- New Transdermal Drug Applications and Approvals
- Electrotransport Drug Delivery
- Iontophoresis
- Transmucosal Drug Delivery
- Oral Transmucosal Fentanyl Citrate (OTFC)
- Transmucosal Etomidate
- Ondansetron ODT
- Buccal Drug Delivery
- Vaginal Drug Delivery
CHAPTER three: Trends and Developments
- Innovations in Transdermal Drug Delivery
- Adhesive Technology and Issues
- Adhesive Market Issues
- Biotechnological Issues
- Iontophoresis and Sonophoresis
- Developments in Insulin Delivery
- New Developments in Hormone Drug Delivery
- New Mucosal/Buccal Delivery Systems
- Other New Drug Delivery Systems
- Macroflux Technology
- Controlled Thermal Energy Technology
- New Ultrasound Technology
- Combination Delivery Technology
- Transdermal Products in Development
CHAPTER four: Market Size and Growth
- The Total Transdermal/Transmucosal Drug Delivery Market
- Transdermal/Transmucosal Delivery Technology Only Market
CHAPTER five: Competitive Analysis
- Competitive Landscape
- Market Analysis
CHAPTER SIX: Company Profiles
- 3M Pharmaceuticals
- Acrux Limited
- Altea Therapeutics, Inc
- ALZA Corporation
- Antares Pharma, Inc.
- Aveva Drug Delivery Systems
- Cardinal Health
- Cephalon Inc
- Generex Biotechnology Corporation
- Inovio Biomedical Corporation
- Labtec GmbH
- Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
- MacroChem Corporation
- NexMed, Inc.
- Noven Pharmaceuticals, Inc.
- SkyePharma PLC
Appendix
Company Directory
Table of exhibits
CHAPTER two: Introduction and Overview
- Table 2-1: Sequence of Drug Action
CHAPTER three: Trends and Developments
- Table 3-1: Selected Transdermal Products in Development
CHAPTER four: Market Size and Growth
- Table 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery
Technology and Pharmaceuticals 2002-2010
- Figure 4-1: The Worldwide Market for Transdermal/Transmucosal Drug
Delivery Technology and Pharmaceuticals 2002-2010
- Table 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/
Transmucosal Drug Delivery Systems by Type 2002-2010
- Figure 4-2: The Worldwide Market for Pharmaceuticals Utilizing
Transdermal/ Transmucosal Drug Delivery Systems Revenues by Type 2002-2010
- Table 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/
Transmucosal Drug Delivery Technologies Market Share by Type 2002-2010
- Figure 4-3: The Worldwide Market for Pharmaceuticals Utilizing
Transdermal/ Transmucosal Drug Delivery Technologies by Type 2006
- Figure 4-4: The Worldwide Market for Pharmaceuticals Utilizing
Transdermal/ Transmucosal Drug Delivery Technologies by Type 2010
- Table 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery
Systems by Pharmaceutical and Drug Delivery Component 2002-2010
- Table 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery
Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component
2002-2010
- Figure 4-5: The Worldwide Market for Transdermal/Transmucosal Drug
Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery
Component 2002-2010
- Figure 4-6: The Worldwide Market for Transdermal/Transmucosal Drug
Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery
Component 2006
- Figure 4-7: The Worldwide Market for Transdermal/Transmucosal Drug
Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery
Component 2010
CHAPTER five: Competitive Analysis
- Table 5-1: Leading Suppliers of Transdermal/Transmucosal Drug Delivery
Technology
医薬品
その他のカテゴリ
FAQ